[Primary metastasized hypernephroma: therapy and follow-up].
Out of 44 patients suffering from disseminated renal cell carcinoma 24/44 patients (group I) underwent nephrectomy, in 20/44 patients the primary tumor was not removed. In 12/44 patients chemotherapy was performed (7 patients group I, 5 patients group II). Comparison of the survival rate with and without chemotherapy revealed no significant difference in the two groups. Partial response was noted only in four patients with a mean duration of four months. These results can not give a final answer for the indication of chemotherapy in metastatic renal cancer.
Hienert
V G
VG
Urologische Universitätsklinik Wien.
Latal
D
D
Kühböck
J
J
Rummelhardt
S
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000601:surgery*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009392:Nephrectomy
Das primär metastasierte Hypernephrom: Therapie und Verlauf.